Effect of Sporlac on Blood Sugar Levels

Evaluation of the effect of pretreatment with Sporlac on the Glycemic response to food in healthy volunteers. - SPBSL

Status

Active, not recruiting

Phases

Phase 3

Study type

Observational

Source

CTRI

Registry ID

CTRI/2017/12/010802

Enrollment

Registered

2017-12-07

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Diabetes

Interventions

Intervention1: SPORLAC: A Probiotic, containing spores of Bacillus Coagulans - SNZ 1969 (500 Million CFU) twice daily. Total duration of treatment 6 days from day 2 after informed consent.

Eligibility

Inclusion criteria

Inclusion criteria: 1.Healthy adult males between 40 and 60 years of age 2.Subjects providing written informed consent

Exclusion criteria

Exclusion criteria: 1.Subjects with impaired glucose tolerance 2.Subjects with known allergy to Sporlac or its constituents 3.Subjects with any disorder that might affect their GI function 4.Patients with active liver or kidney disease

Design outcomes

Primary

Measure	Time frame
To assess the effect of pre-treatment with Sporlac on fasting blood sugar and glycaemic response to foodTimepoint: 9 Days	—

Secondary

Measure	Time frame
To assess the safety of Sporlac in healthy individualsTimepoint: 9 Days	—

Countries

India

Contacts

Public ContactDrAlmas Pathan

JehangirClinicalDevelopmentCenterPvtLtd

almas.jikare@rediffmail.com09763002830

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026